TScan Therapeutics, Inc. Contracts & Agreements
42 Contracts & Agreements
- Business Finance (11 contracts)
- Business Operations (6)
- Human Resources (16)
- Intellectual Property (3)
- Real Estate (3)
- Uncategorized (3)
- Amended and Restated TScan Therapeutic, Inc. 2021 Equity Incentive Plan (Filed With SEC on June 14, 2024)
- Employment Agreement, dated January 29, 2024, by and between the Registrant and Jason A. Amello (Filed With SEC on May 13, 2024)
- Underwriting Agreement dated April 16, 2024 (Filed With SEC on April 17, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on April 17, 2024)
- Employment Agreement, dated May 25, 2023, by and between the Registrant and Gavin MacBeath, Ph.D (Filed With SEC on March 6, 2024)
- Employment Agreement, dated July 28, 2021, by and between the Registrant and Zoran Zdraveski (Filed With SEC on March 6, 2024)
- First Amendment to Lease by and between PPF OFF 828-830 Winter Street LLC and the Registrant, dated November 8, 2023 (Filed With SEC on November 9, 2023)
- Collaboration Agreement by and between the Registrant and Amgen, Inc., dated as of May 8, 2023 (Filed With SEC on August 10, 2023)
- Amendment No. 1 to TScan Therapeutics, Inc. 2021 Equity Incentive Plan (Filed With SEC on June 16, 2023)
- Underwriting Agreement dated May 25, 2023 (Filed With SEC on May 31, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on May 31, 2023)
- Sales Agreement, by and between TScan Therapeutics, Inc. and Wedbush Securities Inc., dated May 16, 2023 (Filed With SEC on May 16, 2023)
- Loan and Security Agreement, dated September 9, 2022, by and among TScan Therapeutics, Inc., K2 HealthVentures LLC and Ankura Trust Company, LLC (Filed With SEC on September 12, 2022)
- Employment Agreement, dated June 8, 2022, by and between the Registrant and Debora Barton (Filed With SEC on August 10, 2022)
- Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on March 9, 2022)
- Lease, by and between TScan Therapeutics, Inc. and BXP Waltham Woods LLC, dated November 29, 2021 (Filed With SEC on December 2, 2021)
- Employment Agreement, dated July 28, 2021, by and between the Registrant and Zoran Zdraveski (Filed With SEC on November 10, 2021)
- 2021 Equity Incentive Plan and form of agreements thereunder (Filed With SEC on May 5, 2021)
- Employment Agreement, dated May 4, 2021, by and between the Registrant and Brian Silver (Filed With SEC on May 5, 2021)
- Form of Underwriting Agreement (Filed With SEC on April 30, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on April 30, 2021)
- Fourth Amended and Restated Investors Rights Agreement, dated January 15, 2021, by and among the Registrant and the other parties thereto (Filed With SEC on April 23, 2021)
- Registration Rights Agreement made as of January 15, 2021 by and between the Registrant and the other parties thereto (Filed With SEC on April 23, 2021)
- Amended and Restated Nominating Agreement, dated April 22, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on April 23, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on April 23, 2021)
- 2018 Stock Plan, as amended, and forms of agreements thereunder (Filed With SEC on April 23, 2021)
- 2021 Equity Incentive Plan and form of agreements thereunder (Filed With SEC on April 23, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on April 23, 2021)
- Amended and Restated Exclusive Patent License Agreement by and between the Registrant and The Brigham and Womens Hospital, Inc. dated April 20, 2021 (Filed With SEC on April 23, 2021)
- Lease by and between PPF OFF 828-830 Winter Street LLC and the Registrant, dated August 13, 2019 (Filed With SEC on April 23, 2021)
- Option & Exclusive License Agreement by and between the Registrant and QIAGEN Sciences LLC, dated as of November 5, 2020 (Filed With SEC on April 23, 2021)
- Collaboration and License Agreement by and between the Registrant and Novartis Institutes for Biomedical Research, dated as of March 27, 2020 (Filed With SEC on April 23, 2021)
- Non-Exclusive License Agreement by and between the Registrant and Provincial Health Services Authority, dated as of October 15, 2020 (Filed With SEC on April 23, 2021)
- Amended and Restated Royalty Agreement, dated as of June 12, 2018 (Filed With SEC on April 23, 2021)
- Services Agreement by and between Christoph Westphal and the Registrant, dated October 9, 2018 (Filed With SEC on April 23, 2021)
- Amendment No. 1 to Services Agreement Services Agreement by and between Christoph Westphal and the Registrant, dated June 24, 2019 (Filed With SEC on April 23, 2021)
- Employment Agreement, dated April 23, 2021, by and between the Registrant and David Southwell (Filed With SEC on April 23, 2021)
- Employment Letter Agreement, dated April 23, 2021, by and between the Registrant and Gavin MacBeath, Ph.D (Filed With SEC on April 23, 2021)
- Employment Letter Agreement, dated April 8, 2019, by and between the Registrant and Henry Rath (Filed With SEC on April 23, 2021)
- Separation Agreement, dated January 26, 2021, by and between the Registrant and Henry Rath (Filed With SEC on April 23, 2021)
- Employment Letter Agreement, dated April 23, 2021, by and between the Registrant and William Desmarais (Filed With SEC on April 23, 2021)
- Form of Management Cash Incentive Plan (Filed With SEC on April 23, 2021)
